William W. Motley, D.Phil.
Affiliations: | Physiology, Anatomy and Genetics | University of Oxford, Oxford, United Kingdom |
Google:
"William Motley"Mean distance: 20.94 (cluster 28)
Parents
Sign in to add mentor| Kenneth H. Fishbeck | grad student | 2006-2010 | National Institute of Health |
| Kevin Talbot | grad student | 2006-2010 | Oxford |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hain HS, Pandey R, Bakay M, et al. (2021) Inducible knockout of Clec16a in mice results in sensory neurodegeneration. Scientific Reports. 11: 9319 |
| Motley WW, Züchner S, Scherer SS. (2020) Isoform-specific loss of dystonin causes hereditary motor and sensory neuropathy. Neurology. Genetics. 6: e496 |
| Sullivan JM, Motley WW, Johnson JO, et al. (2020) Dominant mutations of the Notch ligand Jagged1 cause peripheral neuropathy. The Journal of Clinical Investigation |
| Dankwa L, Richardson J, Motley WW, et al. (2018) A novel MFN2 mutation causes variable clinical severity in a multi-generational CMT2 family. Neuromuscular Disorders : Nmd |
| Meister-Broekema M, Freilich R, Jagadeesan C, et al. (2018) Myopathy associated BAG3 mutations lead to protein aggregation by stalling Hsp70 networks. Nature Communications. 9: 5342 |
| Dankwa L, Richardson J, Motley WW, et al. (2018) A mutation in the heptad repeat 2 domain of MFN2 in a large CMT2A family. Journal of the Peripheral Nervous System : Jpns |
| Bengoechea R, Motley W, Bird S, et al. (2017) A novel BAG3 mutation associated with myofibrillar myopathy emphasizes HSP70 dependent activity Neuromuscular Disorders. 27: S120 |
| Auer-Grumbach M, Toegel S, Schabhüttl M, et al. (2016) Rare Variants in MME, Encoding Metalloprotease Neprilysin, Are Linked to Late-Onset Autosomal-Dominant Axonal Polyneuropathies. American Journal of Human Genetics. 99: 607-623 |
| Motley WW, Palaima P, Yum SW, et al. (2016) De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease. Brain : a Journal of Neurology |
| Grice SJ, Sleigh JN, Motley WW, et al. (2015) Dominant, toxic gain-of-function mutations in gars lead to non-cell autonomous neuropathology. Human Molecular Genetics. 24: 4397-406 |